Reference 1 - Draft Guidance on Dabrafenib Mesylate
FDA-2026-P-6541-0003Supporting & Related Material
Document
Details
The document's own metadata, straight from the source system.
- Title
- Reference 1 - Draft Guidance on Dabrafenib Mesylate
- Posted
- Jun 9, 2026
- Topics
